1 |
Tohumeken S, Deme P, Yoo SW, Gupta S, Rais R, Slusher BS, Haughey NJ. Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons. Neurobiol Dis 2023;177:105987. [PMID: 36603748 DOI: 10.1016/j.nbd.2023.105987] [Reference Citation Analysis]
|
2 |
Tallon C, Bell BJ, Sharma A, Pal A, Malvankar MM, Thomas AG, Yoo SW, Hollinger KR, Coleman K, Wilkinson EL, Kannan S, Haughey NJ, Kannan RM, Rais R, Slusher BS. Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice. Pharmaceutics 2022;14. [PMID: 36297501 DOI: 10.3390/pharmaceutics14102066] [Reference Citation Analysis]
|
3 |
Mccluskey G, Donaghy C, Morrison KE, Mcconville J, Duddy W, Duguez S. The Role of Sphingomyelin and Ceramide in Motor Neuron Diseases. JPM 2022;12:1418. [DOI: 10.3390/jpm12091418] [Reference Citation Analysis]
|
4 |
Pal A, Gori S, Yoo SW, Thomas AG, Wu Y, Friedman J, Tenora L, Bhasin H, Alt J, Haughey N, Slusher BS, Rais R. Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP. J Med Chem 2022;65:11111-25. [PMID: 35930706 DOI: 10.1021/acs.jmedchem.2c00562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Li F, Kang X, Xin W, Li X. The Emerging Role of Extracellular Vesicle Derived From Neurons/Neurogliocytes in Central Nervous System Diseases: Novel Insights Into Ischemic Stroke. Front Pharmacol 2022;13:890698. [PMID: 35559228 DOI: 10.3389/fphar.2022.890698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|